查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1627576

临床实践中的人工智慧：预测（2025-2030）

AI in Clinical Settings Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

临床环境中的AI市场预计将以37.5%的复合年增长率成长。

临床人工智慧市场的发展受到对改善患者治疗效果和诊断效率的需求不断增长以及医疗保健领域大量资料的推动。

它还在许多方面改变医疗保健，包括医学影像分析、药物开发、精准医疗、诊断和治疗管理以及临床影像处理。

此外，人工智慧可以透过识别适合所需治疗的患者特征来促进适当的治疗处方。人工智慧辅助系统也为实际应用带来临床决策支持，使医疗保健专业人员能够做出决策。

临床实务中人工智慧的市场驱动因素

  • 医疗成本上涨

医疗费用上涨是医疗保健系统面临的全球性问题。这些与多种因素有关，包括人口老化、技术创新、行政复杂性、药物成本、防御性医疗以及医疗保健效率低下。此外，根据“2030愿景”计划，沙乌地阿拉伯政府将投资超过650亿美元发展医疗基础设施，重组和私有化保险和医疗服务，并在全国建立21个“健康丛集”，并打算提高电子健康服务。同样，其目标到 2030 年将私部门的参与率从 40% 提高到 65%。此举将导致 290 家医院和 2,300 家初级卫生中心私有化，为投资沙乌地阿拉伯不断扩大的医疗保健市场的美国公司创造重大商机。

随着人口老化，对医疗保健服务的需求日益增长，尤其是针对慢性疾病和与老龄化相关的疾病。需求的增加导致医疗资源紧张并推高了成本。此外，医疗索赔、计费和法规合规等管理成本也增加了成本负担。

临床环境中人工智慧的地理前景：

  • 临床 AI 市场分为全球五个区域：

根据地区，临床环境中的人工智慧市场细分为北美、南美、欧洲、中东和非洲以及亚太地区。北美临床环境中的人工智慧市场主要受到强大的医疗保健基础设施、对医疗保健技术和研究的大量投资以及鼓励创新和采用人工智慧解决方案的有利法规环境的推动。根据美国医学会预测，2022年美国在医疗保健方面的支出将达到44644亿美元，其中医院占30.4%，医生服务占14.5%，临床服务占5.3%，居家医疗占3%。 4.3%）、处方药（9.1%）、其他个人照护（16.5%）、医疗保险净成本（6.3%）、政府行政（1.2%）和政府公共卫生活动（4.7%）以及投资（4.9%）。

同时，亚太地区临床人工智慧市场受到多种因素推动，包括快速成长的医疗保健产业、庞大的人口和不断上涨的医疗成本。慢性病发病率的上升以及政府支持人工智慧应用的措施和政策正在推动市场成长。例如，印度2016年报告了37,416例前列腺癌病例，2020年增加到41,532例。到 2025 年，前列腺癌病例数预计将增加到 47,000 多例。这一数字约占全国所有癌症患者的3%。此外，印度前列腺癌的平均发病年龄为 69.7 岁。此外，可支配收入的增加以及医疗专业人士和患者对人工智慧益处的认识不断提高，也促进了该地区市场的扩张。

为什么要购买这份报告？

  • 深刻的分析：获得深入的市场洞察，涵盖主要地区和新兴地区，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透率。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问公司、中小企业和大型企业都有益且具有成本效益。

它有什么用途？

产业与市场分析、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2030 年的实际资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略与市场占有率分析
  • 各地区（包括细分市场和国家）的收益成长和预测分析
  • 公司概况（策略、产品、财务、主要发展等）

目录

第 1 章 简介

  • 市场概况
  • 市场定义
  • 研究范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 研究过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析

第 5 章 临床 AI 市场（依技术划分）

  • 介绍
  • 机器学习
  • 自然语言处理
  • 电脑视觉
  • 机器人

第六章 临床 AI 市场（以最终用户划分）

  • 介绍
  • 医院和诊所
  • 製药和生物技术公司
  • 医疗设备公司
  • 研究所

第七章 临床 AI 市场（按地区）

  • 世界概况
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 台湾
    • 泰国
    • 印尼
    • 其他亚太地区

第八章 竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第九章 公司简介

  • IQVIA
  • AiCure
  • Google Health
  • DeepScribe
  • Siemens Healthineers
  • Nuance Communications
  • Care.ai
  • Qure AI
  • NVIDIA
  • Arm
简介目录
Product Code: KSI061617232

The AI in clinical settings market is anticipated to grow at a CAGR of 37.5%.

The AI in clinical settings market is growing significantly due to the enhanced requirements for improving patient outcomes and diagnostic efficiency and the large volume of data in health care.

It is also transforming health care from different fronts, such as medical image analysis, drug development, precision medication, diagnostic and treatment administration, and clinical image processing.

Moreover, AI promotes prescribing the right treatment by identifying patient characteristics to suit the required treatment. AI-aided systems also bring clinical decision support for practical uses, enabling healthcare professionals to arrive at decisions.

AI in the clinical settings market drivers:

  • Rising healthcare costs

The high cost of health care is a global problem for the healthcare system. These are associated with various factors such as the aging population, technological innovation, administrative complexities, cost of drugs, defensive medicine, and healthcare delivery inefficiency. In addition to this, the Saudi Arabian government intends to invest more than $65 billion under Vision 2030 to build its healthcare infrastructure, restructure and privatize insurance and health services, establish 21 "health clusters" nationwide, and increase the availability of e-health services. Similarly, private sector participation is aiming to increase from 40% to 65% by 2030. This would entail the privatization of 290 hospitals and 2300 primary health centers, thus creating considerable business opportunities for American companies investing in Saudi Arabia's expanding healthcare market.

With the aging population, demand for healthcare services expands, mainly in chronic diseases and age-related conditions. This increase in demand can strain healthcare resources while raising costs. Moreover, administrative costs such as healthcare insurance claims, billing, and regulatory compliance will increase the cost burden.

AI in clinical settings market geographical outlook:

  • The AI in clinical settings market is segmented into five regions worldwide:

Geography-wise, the market of AI in clinical settings is divided into North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The North American AI in clinical settings market is largely driven by a strong healthcare infrastructure, large-scale investment in healthcare technology and research, and an excellent regulatory environment that fosters innovation and adoption of AI-enabled solutions. According to the American Medical Association, the United States spent $4,464.4 billion on health care in 2022 which was divided into different segments out of which hospital care accounted for 30.4% share, followed by physician service (14.5%), clinical services (5.3%), home health care (3%), nursing care facilities (4.3%), prescription drugs (9.1%), other personal health care (16.5%), the net cost of health insurance (6.3%), government administration (1,2%), government public health activities (4.7%), and investment (4.9%).

On the other hand, several factors drive the Asia Pacific AI in the clinical settings market, including a rapidly growing healthcare sector, a large population, and rising healthcare costs. The increasing prevalence of chronic diseases and government initiatives and policies supporting AI adoption are accelerating market growth. For instance, India reported 37,416 cases of prostate cancer in 2016, and by 2020, that number had risen to 41,532 cases. By 2025, the incidence of prostate cancer is predicted to rise to over 47,000 cases. This figure represents approximately 3% of all cancer cases in the nation. Additionally, in India, the average age at which prostate cancer occurs is 69.7 years. Moreover, rising disposable incomes and growing awareness of AI's benefits among healthcare providers and patients are contributing to the regional market expansion.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The AI in clinical settings market is segmented and analyzed as follows:

By Technology

  • Machine Learning
  • Natural Language Processing
  • Computer Vision
  • Robotics

By End-User

  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Research Institutions

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Rest of the Middle East and Africa
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Rest of Asia-Pacific

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. AI IN CLINICAL SETTINGS MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Machine Learning
  • 5.3. Natural Language Processing
  • 5.4. Computer Vision
  • 5.5. Robotics

6. AI IN CLINICAL SETTINGS MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals and Clinics
  • 6.3. Pharmaceutical and Biotechnology Companies
  • 6.4. Medical Device Companies
  • 6.5. Research Institutions

7. AI IN CLINICAL SETTINGS MARKET BY GEOGRAPHY

  • 7.1. Global Overview
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Rest of South America
  • 7.4. Europe
    • 7.4.1. United Kingdom
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Rest of Europe
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. United Arab Emirates
    • 7.5.3. Rest of the Middle East and Africa
  • 7.6. Asia-Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Taiwan
    • 7.6.6. Thailand
    • 7.6.7. Indonesia
    • 7.6.8. Rest of Asia-Pacific

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. IQVIA
  • 9.2. AiCure
  • 9.3. Google Health
  • 9.4. DeepScribe
  • 9.5. Siemens Healthineers
  • 9.6. Nuance Communications
  • 9.7. Care.ai
  • 9.8. Qure AI
  • 9.9. NVIDIA
  • 9.10. Arm